Commonwealth Equity Services’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-43,265
Closed -$2.7M 4409
2025
Q3
$2.7M Buy
43,265
+3,602
+9% +$251K ﹤0.01% 1779
2025
Q2
$3.17M Buy
+39,663
New +$3.32M ﹤0.01% 1655
2016
Q2
Sell
-4,807
Closed -$257K 2280
2016
Q1
$257K Hold
4,807
﹤0.01% 1741
2015
Q4
$247K Buy
4,807
+349
+8% +$17.3K ﹤0.01% 1741
2015
Q3
$201K Buy
+4,458
New +$211K ﹤0.01% 1835

Other funds holding PBH

Commonwealth Equity Services's PBH Position: Q4 2025 in Review

Commonwealth Equity Services sold out of Prestige Consumer Healthcare (PBH) in Q4 2025, closing a stake of 43,265 shares — an estimated $2.7M sold.

Commonwealth Equity Services first reported a position in PBH in Q3 2015 and held it in 5 quarters. The position peaked at $3.17M in Q2 2025. 354 funds tracked by Wall St. Rank hold PBH as of Q4 2025.

  • Commonwealth Equity Services reported no remaining Prestige Consumer Healthcare position as of Q4 2025 after selling out during the quarter.
  • Commonwealth Equity Services sold 43,265 Prestige Consumer Healthcare shares in Q4 2025, an estimated $2.7M.
  • Commonwealth Equity Services first reported a position in Prestige Consumer Healthcare in Q3 2015 and held it in 5 quarters.
  • Commonwealth Equity Services's Prestige Consumer Healthcare position peaked at $3.17M in Q2 2025.
  • 354 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2025.

Based on Commonwealth Equity Services's 13F filing for Q4 2025, filed 12 Feb 2026.